Every Form 4 that Bausch + Lomb Corporation (BLCO) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BLCO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BLCO filings page.
Bausch & Lomb Corp reported that EVP & Chief Legal Officer A. Robert D. Bailey acquired an equity award of 52,570 restricted share units (RSUs) on common shares at a stated price of $0.00 per share. These RSUs were granted under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan.
The RSUs are scheduled to vest one-third on each of the first three anniversaries of the grant date, generally requiring Mr. Bailey’s continued service. After this award, his direct holdings in common shares total 223,146 shares, highlighting ongoing stock-based compensation tied to long-term service.
Bausch & Lomb Corp reported that EVP and CFO Sam Eldessouky acquired 81,775 common shares through a grant of restricted share units (RSUs) at a price of $0.00 per share. After this award, he directly holds 473,169 common shares.
The RSUs were granted under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan. They are scheduled to vest in three equal installments on each of the first three anniversaries of the grant date, generally requiring his continued service. Once vested, the RSUs will be settled in common shares of Bausch & Lomb Corporation.
SAUNDERS BRENT L reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp CEO and chairman Brent L. Saunders received an equity grant of 327,102 restricted share units under the company’s 2022 Omnibus Incentive Plan. These RSUs vest in three equal annual installments and settle in common shares upon vesting. After this award, he holds 998,583 common shares directly.
Bausch & Lomb Corp CEO and Chairman Brent L. Saunders reported a tax-related share disposition. On February 23, 2026, 65,444 common shares at $17.99 per share were withheld to cover tax obligations upon vesting of restricted share units. After this withholding, Saunders beneficially owned 671,481 common shares directly.
Bausch & Lomb director Steven H. Collis reported two transactions in common shares. He made an open-market purchase of 15,000 shares at a weighted average price of $17.81 per share, increasing his direct holdings. He also received 4,491 matching restricted share units (MRSUs) granted under the company’s matching share program, tied to this purchase. One-third of these MRSUs will vest on each of the first, second, and third anniversaries of the grant, subject to his continued service. Following these transactions, he directly owned 24,746 common shares.
Bausch & Lomb director Russel C. Robertson increased his stake in the company through both a purchase and an equity award. He bought 4,400 common shares in an open-market transaction at $17.90 per share. On the same date, he also acquired 4,400 matching restricted share units at no cost under the company’s matching share program.
Following these transactions, his direct holdings rose to 76,807 common shares. The matching restricted share units will vest in three equal installments on the first, second, and third anniversaries of the grant date, as long as he continues to serve, except in limited circumstances.
Bausch & Lomb Corp director Karen Ling reported new purchases and awards of common shares. On February 19, 2026, she made an open-market purchase of 4,000 common shares at a weighted average price of $17.742 per share, with individual trades ranging from $17.71 to $17.75. She also acquired 4,000 matching restricted share units in connection with this purchase under the company’s matching share program, which vest in three equal annual installments starting one year after the grant date, subject to continued service.
Bausch & Lomb Corp reported that director Steven H. Collis acquired 5,255 common shares through an annual grant of restricted share units (RSUs) for non-employee directors. The RSUs were granted at no cash cost and are scheduled to vest immediately before the company’s next annual shareholder meeting.
Bausch & Lomb Corp director Alfonso Eduardo reported acquiring 5,255 common shares through an annual grant of restricted share units under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated.
The RSUs will be settled in common shares and are scheduled to vest immediately prior to the next annual meeting of shareholders.
Bausch & Lomb Corp director Russel C. Robertson acquired 1,451 restricted share units on common shares through a grant. The award was valued at $17.65 per share and increased his directly held position to 68,007 common shares, aligning his compensation partly with shareholder value.
Bausch & Lomb Corp director John Paulson received an equity grant of 1,239 restricted share units on common shares at a reference price of $17.65 per share. These units each represent a contingent right to receive one common share with no par value.
Following this grant, Paulson directly holds 72,606 common shares of Bausch & Lomb Corp. This transaction is reported as a grant, award, or other acquisition rather than an open-market purchase.
Bausch & Lomb Corp executive Frederick Munsch, SVP, Controller and CAO, reported acquiring 12,498 common shares at a price of $0.00 per share. These shares relate to performance stock units granted on March 1, 2023 that satisfied performance conditions as of February 18, 2026.
The earned PSUs will vest on March 1, 2026, generally contingent on Munsch’s continued employment through that date. Following this award, his directly held stake increased to 90,231 common shares.
Bonnefoy Luc reported acquisition or exercise transactions in this Form 4 filing.
Bausch & Lomb Corp President, Surgical, Luc Bonnefoy reported an equity award involving 10,202 common shares of the company. These shares relate to performance stock units granted on March 1, 2023 that met their performance conditions as of February 18, 2026. The earned units are scheduled to vest on March 1, 2026, generally conditioned on his continued employment, bringing his reported direct holdings to 87,564 common shares.
Bausch & Lomb Corp EVP of R&D and CMO Yehia Hashad reported an equity award acquisition. He earned 29,406 common shares underlying performance stock units originally granted on March 1, 2023 after the award satisfied its performance conditions as of February 18, 2026.
The earned PSUs will convert into common shares and vest on March 1, 2026, generally contingent on his continued employment through that date. Following this award, Hashad’s direct holdings total 163,860 common shares, aligning his compensation more closely with the company’s long-term performance.
Bausch & Lomb Corp EVP and CFO Sam Eldessouky reported an equity award tied to performance. He acquired 70,578 common shares underlying performance stock units that met performance conditions as of February 18, 2026, from a grant originally made on March 1, 2023.
The earned performance stock units will vest on March 1, 2026, generally contingent on his continued employment through that date. Following this non-cash grant/award acquisition, his directly owned common shares total 391,394.
Bausch & Lomb Corp (BLCO) reported that one of its directors acquired additional equity in the company. On 11/14/2025, the director acquired 1,642 common shares at a price of $15.60 per share. Following this transaction, the director beneficially owns 66,556 common shares in total, held directly. An accompanying note explains that the reported amount reflects restricted share units, each representing a contingent right to receive one common share of Bausch + Lomb Corporation.
Bausch & Lomb Corp. director reports equity award under Form 4. A company director acquired 1,402 common shares of Bausch & Lomb Corp. on 11/14/2025, coded as an acquisition and priced at $15.60 per share. After this transaction, the director beneficially owned a total of 71,367 common shares held directly. The new shares are in the form of restricted share units, each representing a contingent right to receive one common share of Bausch & Lomb Corporation.